404 related articles for article (PubMed ID: 30293530)
1. Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.
Mandro M; Suykerbuyk P; Tepage F; Rossy D; Ngave F; Hasan MN; Hotterbeekx A; Mambandu G; Kashama JM; Laudisoit A; Colebunders R
Infect Dis Poverty; 2018 Oct; 7(1):79. PubMed ID: 30293530
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.
Lenaerts E; Mandro M; Mukendi D; Suykerbuyk P; Dolo H; Wonya'Rossi D; Ngave F; Ensoy-Musoro C; Laudisoit A; Hotterbeekx A; Colebunders R
Infect Dis Poverty; 2018 Aug; 7(1):68. PubMed ID: 30064504
[TBL] [Abstract][Full Text] [Related]
4. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
Levick B; Laudisoit A; Tepage F; Ensoy-Musoro C; Mandro M; Bonareri Osoro C; Suykerbuyk P; Kashama JM; Komba M; Tagoto A; Falay D; Begon M; Colebunders R
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005732. PubMed ID: 28708828
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D; Tepage F; Akonda I; Siewe JNF; Rotsaert A; Ndibmun CN; Laudisoit A; Couvreur S; Kabutako B; Menon S; Hotterbeekx A; Colebunders R
Int J Infect Dis; 2019 Feb; 79():187-194. PubMed ID: 30711145
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo.
Colebunders R; Tepage F; Rood E; Mandro M; Abatih EN; Musinya G; Mambandu G; Kabeya J; Komba M; Levick B; Mokili JL; Laudisoit A
PLoS Negl Trop Dis; 2016 May; 10(5):e0004478. PubMed ID: 27139245
[TBL] [Abstract][Full Text] [Related]
8. The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania.
König R; Nassri A; Meindl M; Matuja W; Kidunda AR; Siegmund V; Bretzel G; Löscher T; Jilek-Aall L; Schmutzhard E; Winkler AS
Parasitology; 2010 Sep; 137(10):1559-68. PubMed ID: 20388236
[TBL] [Abstract][Full Text] [Related]
9. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.
Colebunders R; Hendy A; Mokili JL; Wamala JF; Kaducu J; Kur L; Tepage F; Mandro M; Mucinya G; Mambandu G; Komba MY; Lumaliza JL; van Oijen M; Laudisoit A
BMC Res Notes; 2016 Mar; 9():182. PubMed ID: 27005304
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
11. Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo.
Dolo H; Mandro M; Wonya'Rossi D; Ngave F; Fraeyman J; Siewe JN; Suykerbuyk P; Colebunders R
Infect Dis Poverty; 2018 Dec; 7(1):115. PubMed ID: 30509330
[TBL] [Abstract][Full Text] [Related]
12. Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic.
Druet-Cabanac M; Preux PM; Bouteille B; Bernet-Bernady P; Dunand J; Hopkins A; Yaya G; Tabo A; Sartoris C; Macharia W; Dumas M
Am J Epidemiol; 1999 Mar; 149(6):565-70. PubMed ID: 10084246
[TBL] [Abstract][Full Text] [Related]
13. Baseline characterization of epilepsy in an onchocerciasis endemic area of the Democratic Republic of Congo.
Burfeind KG; Kashama JK; Bora BK; Murchison CF; Ramos-Crawford AL; Nseka MT; Kunyu SB; Okitundu DL; Mashukano NL; Banea JM; Boivin Michael J; Mwanza JK; Mumba D; Tshala-Katumbay DD
Brain Res Bull; 2019 Feb; 145():45-52. PubMed ID: 30468846
[TBL] [Abstract][Full Text] [Related]
14. Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor.
Amaral LJ; Bhwana D; Mhina AD; Mmbando BP; Colebunders R
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011434. PubMed ID: 37339148
[TBL] [Abstract][Full Text] [Related]
15. Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on
Hadermann A; Jada SR; Sebit WJ; Deng T; Bol YY; Siewe Fodjo JN; De Coninck L; Matthijnssens J; Mertens I; Polman K; Colebunders R
F1000Res; 2023; 12():1262. PubMed ID: 38439783
[TBL] [Abstract][Full Text] [Related]
16. Comparison of PCR Methods for
Prince-Guerra JL; Cama VA; Wilson N; Thiele EA; Likwela J; Ndakala N; Muzinga Wa Muzinga J; Ayebazibwe N; Ndjakani YD; Pitchouna NA; Mumba D; Tshefu AK; Ogawa G; Cantey PT
Am J Trop Med Hyg; 2018 May; 98(5):1427-1434. PubMed ID: 29611501
[TBL] [Abstract][Full Text] [Related]
17. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
18. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda.
Ovuga E; Kipp W; Mungherera M; Kasoro S
East Afr Med J; 1992 Oct; 69(10):554-6. PubMed ID: 1473507
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.
Bhwana D; Mmbando BP; Dusabimana A; Mhina A; Challe DP; Fodjo JNS; Makunde WH; Colebunders R
Afr Health Sci; 2022 Sep; 22(3):607-616. PubMed ID: 36910370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
